Piazza Antonina, Poggi Elvira, Ozzella Giuseppina, Borrelli Laura, Monaco Palmina I, Scornajenghi Alessandra, Tisone Giuseppe, Adorno Domenico
National Council of Research, Institute of Organ Transplantation and Immunocytology, Rome, Italy.
Transplantation. 2006 May 15;81(9):1298-305. doi: 10.1097/01.tp.0000209654.87584.c5.
Patients whose kidney grafts fail develop alloantibodies that react with many HLA molecules. We analyzed the epitope specificity of HLA class I alloantibodies in the sera of 55 patients who had been sensitized by kidney grafts, and investigated the immunogenicity of various polymorphic epitopes.
HLA class I alloantibodies were detected and characterized by flow cytometry (FlowPRA beads). Potential "immunizing epitopes" were identified by comparing the amino acid sequences of HLA class I antigens/alleles of the donor, recipient and the antibody-reactivity pattern.
In the 55 anti-HLA class I-positive patients, 82 different antibody reactivity patterns were identified; all but 5 (94%) were determined by a "public epitope" of donor HLA-A and/or -B molecules. Forty-five of 50 patients who showed HLA-A Res-MMs with their donors produced HLA-A antibodies, but only 31 of 51 subjects with HLA-B Res-MMs produced HLA-B antibodies (P=0.001; O.R.=5.81). The antibody patterns were specific for a "single" epitope of the mismatched donor molecules in 91% of patients. Forty-three of the 120 (36%) mismatched HLA-A and/or -B epitopes were positively correlated with antibody production. The polymorphic determinants of higher immunogenic capacity were b80N (Bw6-associated) and ab82-83LR (Bw4-associated) public epitopes.
The humoral immune response against a kidney graft mainly produces HLA class I antibodies specific for "public epitopes" of mismatched donor molecules. A "single" donor-epitope may determine the production of a spread antibody pattern. In renal transplantation, epitope matching is better than HLA antigen matching for avoiding or minimizing development of HLA antibodies.
肾移植失败的患者会产生与多种人类白细胞抗原(HLA)分子发生反应的同种抗体。我们分析了55例因肾移植致敏患者血清中HLAⅠ类同种抗体的表位特异性,并研究了各种多态性表位的免疫原性。
采用流式细胞术(FlowPRA微珠法)检测并鉴定HLAⅠ类同种抗体。通过比较供体、受体的HLAⅠ类抗原/等位基因的氨基酸序列以及抗体反应模式,确定潜在的“免疫表位”。
在55例抗HLAⅠ类阳性患者中,鉴定出82种不同的抗体反应模式;除5种(94%)外,均由供体HLA - A和/或 - B分子的“公共表位”决定。50例与供体存在HLA - A错配微小错配(Res - MMs)的患者中有45例产生了HLA - A抗体,但51例存在HLA - B Res - MMs的受试者中只有31例产生了HLA - B抗体(P = 0.001;比值比[O.R.] = 5.81)。91%的患者抗体模式对错配供体分子的“单一”表位具有特异性。120个错配的HLA - A和/或 - B表位中有43个(36%)与抗体产生呈正相关。免疫原性较高的多态性决定簇是b80N(与Bw6相关)和ab82 - 83LR(与Bw4相关)公共表位。
针对肾移植的体液免疫反应主要产生针对错配供体分子“公共表位”的HLAⅠ类抗体。一个“单一”的供体表位可能决定广泛的抗体模式的产生。在肾移植中,表位匹配在避免或最小化HLA抗体产生方面优于HLA抗原匹配。